SATURDAY, MAY 24, 2025
1:20 pm - 1:40 pm

The Risk of Malignancy in IBD

Learning Objectives:

• Understand the risks of malignancy associated with inflammatory bowel disease
• Evaluate the potential malignancy risks associated with inflammatory bowel disease therapies
• Highlight strategies for discussing cancer risk mitigation and treatment risk-benefit considerations with patients and peers

Speaker

Dr. Cara Pray, MB BCh BAO, FRCPC

Staff Gastroenterologist at St. Joseph’s Healthcare Hamilton
Assistant Professor of Medicine at McMaster University

Dr. Cara Pray is a Staff Gastroenterologist at St. Joseph’s Healthcare Hamilton and an Assistant Professor of Medicine at McMaster University. She completed her core Gastroenterology training at McMaster University, where she also pursued an Advanced Inflammatory Bowel Disease (IBD) fellowship.

Dr. Pray’s clinical expertise lies in complex inflammatory bowel disease, with a special interest in optimizing care for patients during pregnancy. She is currently leading the development of a pre-conception and pregnancy clinic at McMaster University to support individuals with IBD throughout their reproductive journey.